Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gertz

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsF Catella-Lawson, B McAdam, B W Morrison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1993
The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal womenS T Harris, B J Gertz, H K Genant, et al.
Journal of Neurotrauma|January 6, 2017
Tripartite Stratification of the Glasgow Coma Scale in Children with Severe Traumatic Brain Injury and Mortality: An Analysis from a Multi-Center Comparative Effectiveness StudySarah Murphy, Neal J Thomas, Shira J Gertz, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Studies of the oral bioavailability of alendronateB J Gertz, S D Holland, W F Kline, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2012
Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot studyTeodoro del Ser, Klaus C Steinwachs, Hermann J Gertz, et al.
Bulletin of the Hospital for Joint Disease (2013)|November 28, 2014
Postoperative spinal fusion care in pediatric patients: Co-management decreases length of stayRebecca E Rosenberg, Kaveh Ardalan, Wai Wong, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2004
Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in GermanyL Froelich, H-J Gertz, R Heun, et al.
MMW Fortschritte Der Medizin|November 3, 2005
[The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs]T Heinen-Kammerer, K Motzkat, D Daniel, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient childrenE Codner, F Cassorla, A N Tiulpakov, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsF Catella-Lawson, B McAdam, B W Morrison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1993
The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal womenS T Harris, B J Gertz, H K Genant, et al.
Journal of Neurotrauma|January 6, 2017
Tripartite Stratification of the Glasgow Coma Scale in Children with Severe Traumatic Brain Injury and Mortality: An Analysis from a Multi-Center Comparative Effectiveness StudySarah Murphy, Neal J Thomas, Shira J Gertz, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Studies of the oral bioavailability of alendronateB J Gertz, S D Holland, W F Kline, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2012
Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot studyTeodoro del Ser, Klaus C Steinwachs, Hermann J Gertz, et al.
Bulletin of the Hospital for Joint Disease (2013)|November 28, 2014
Postoperative spinal fusion care in pediatric patients: Co-management decreases length of stayRebecca E Rosenberg, Kaveh Ardalan, Wai Wong, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2004
Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in GermanyL Froelich, H-J Gertz, R Heun, et al.
MMW Fortschritte Der Medizin|November 3, 2005
[The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs]T Heinen-Kammerer, K Motzkat, D Daniel, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient childrenE Codner, F Cassorla, A N Tiulpakov, et al.
Pageof 25